International Journal of Medical and Pharmaceutical Research
2024, Volume-5, Issue-5 doi: 10.5281/zenodo.12904199
Original Research Article
Impact of New Onset Atrial Fibrillation in Medical ICU of a Tertiary Care Centre: An Observational study
Published
Oct. 30, 2024
Abstract

Background: Atrial fibrillation (AF) is the most common arrhythmia seen in critically ill patients, which leads to mortality and morbidity. Purpose of this study was to assess the impact of new onset AF in critically ill patients.Methods: We have designed an observational study, with participants aged more than or equal to 18 years, having new onset AF in medical ICU from 1st January, 2024 to 30th September, 2024 with previous documentation of normal sinus rhythm.Results: 28 patients developed new onset AF during the study period in medical ICU. 42.8% was of cardiac origin, whereas 57.2 % was of non-cardiac origin. Mortality was higher among AF of non-cardiac origin. Mortality was higher among hemodynamically unstable patients. New onset AF and mortality in this group was directly proportional to SOFA (Sequential Organ Failure Assessment) score.

Recommended Articles
Loading Image...
Volume-5, Issue-5
Citations
1805 Views
81 Downloads
Share this article
License
Copyright (c) International Journal of Medical and Pharmaceutical Research
pdf Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
IJMPR open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Logo
International Journal of Medical and Pharmaceutical Research
About Us
The International Journal of Medical and Pharmaceutical Research (IJMPR) is an EMBASE (Elsevier)–indexed, open-access journal for high-quality medical, pharmaceutical, and clinical research.
Follow Us
© Copyright IJMPR | All Rights Reserved